Clinical Trials Browser

INDUSTRY × Drug-Related Side Effects and Adverse Reactions × Clear all

NCT07169851 2026-03-06

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Phase 2 Recruiting

204 enrolled

Nausea, Neoplasms, Vomiting, Drug-Related Side Effects and Adverse Reactions

NCT07238075 2026-02-17

ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

Phase 1 Recruiting

290 enrolled

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT06120712 2025-12-23

MIZAR-002

Phase 1/2 Completed

18 enrolled

Dermatologic

Melanoma, Drug-Related Side Effects and Adverse Reactions

NCT05417750 2025-12-10

MIZAR-001

Phase 1 Completed

43 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06716619 2025-03-26

A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors

Phase 1 Recruiting

32 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT06302062 2024-12-03

TAL-T

Phase 1 Recruiting

23 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT05137847 2023-12-12

A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)

Completed

118 enrolled

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Drug-Related Side Effects and Adverse Reactions

NCT04770922 2023-02-16

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

Completed

80 enrolled

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT03077477 2018-06-14

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

Phase 1 Withdrawn

Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT00024427 2012-06-28

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Phase 3 Completed

250 enrolled

Gastrointestinal

Pancreatic Neoplasms, Drug-Related Side Effects and Adverse Reactions